Topical delivery of nucleic acids in the skin

S.T.P. Pharma Sciences

Volumn 11, Issue 1, 2001, Pages 57-68

  Preat V ^a   Dujardin, N ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

DNA; DNA immunization; Gene therapy; Nucleic acid; Oligonucleotides; Skin; Topical delivery; Transdermal delivery

Indexed keywords

DNA; LIPID; LIPOSOME; OLIGONUCLEOTIDE; PLASMID DNA;

DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; HUMAN; IMMUNIZATION; KERATINOCYTE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SKIN;

EID: 0035125495     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Reversible skin permeabilisation for transdermal delivery of macromolecules
2. Topicalliposomes targeting of dyes, melanins, genes and proteins selectively to hair follicles
3. Targeted follicular delivery of macromolecules via liposomes
4. Ultrasound-mediated transdermal delivery
5. The use of sonication for the efficient delivery of plasmid DNA into cells
6. Special issue Iontophoresis
7. Iontophoretic delivery of peptides drugs
8. Iontophoresis of poly-L-lysine: The role of molecular weight
9. Theory of electroporation: A review
10. Enhanced drug delivery using high-voltage pulses
11. High-efficiency gene transfer into skeletal muscle mediated by electric pulses
12. Assessing the potential of skin electroporation for the delivery of protein and gene-based drugs
13. Transdermal delivery of macromolecules using skin electroporation
14. Antisense strategies and therapeutic applications
15. Antisense oligonucleotide therapeutics: Drug delivery and targeting
16. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides; A real or magic bullet?
17. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras mediated cell proliferation and tumorigenicity in nude mice
18. Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging
19. Pharmaceutical approach to somatic gene therapy
20. Viral vectors in gene therapy
21. Cationic lipids used in gene transfer
22. From genes to gene medicines: Recent advances in non-viral gene delivery
23. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems
24. Gene-delivery systems using cationic polymers
25. Liposomes in gene therapy
26. Cationic lipid-based gene delivery systems: Pharmaceutical perspectives
27. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
28. Induction and characterisation of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunisation
29. DNA immunisation targeting the skin: Molecular control of adaptive immunity
30. Targeting the skin for genetic immunisation
31. Percutaneous penetration of methyl phosphonate antisense oligonucleotides
32. Percutaneous absorption of antisense phosphorothioate oligonucleotide in vitro
33. Differential regulation of c-fosB, c-junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion
34. Follicular permeation of oligonucleotides
35. Description of the interfollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro
36. Penetration of oligonucleotides into mouse organism through mucosa and skin
37. Iontophoretic delivery of oligonucleotide derivatives into mouse tumour
38. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin
39. Iontophoretic delivery of a telomeric oligonucleotide
40. Effects of size and sequence on the iontophoretic delivery of oligonucleotides
41. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes
42. Transdermal transport of DNA antisense oligonucleotides by electroporation
43. Parameters controlling topical delivery of oligonucleotides by electroporation
44. Localisation of a FITC-labelled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation
45. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation
46. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin
47. Cytokine gene expression in epidermis with biological effects following injection of naked DNA
48. Expression of naked DNA in human, pig, and mouse skin
49. Gene transfer into mammalian cells by jet injection
50. Keratinocyte gene therapy for systemic diseases. Circulating IL-10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin
51. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes
52. Efficient non-viral cutaneous transfection
53. Intradermal gene immunisation: The possible role of DNA uptake in the induction of cellular immunity to viruses
54. Intradermal DNA immunisation by using jet-injectors in mice and monkeys
55. Topical gene delivery to murine skin
56. Immunisation via hair follicles by topical application of naked DNA to normal skin
57. Liposome-mediated gene transfer and expression via the skin
58. The feasibility of targeted selective gene therapy of the hair follicles
59. Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo
60. In vitro transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method
61. Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds
62. Sustainability of keratinocyte gene transfer and cell survival in vivo
63. Sustainable cutaneous gene delivery
64. An ex vivo keratinocytes model for gene therapy of haemophilia B
65. Differentiation specific enhancer activity in transduced keratinocytes: A model for epidermal gene therapy
66. Evidence for keratinocytes stem cells in vitro long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes
67. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors
68. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression
69. Topical application of viral vectors for epidermal gene transfer
70. Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adeno-associated virus vector
71. In vivo gene transfer to skin and wound by microseeding
72. Puncture mediated gene transfer to the skin
73. Intradermal DNA immunisation of mice against influenza A virus using the novel PowderJect system
74. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
75. High efficiency, long-term clinical expression of cottontail rabbit papillomavirus (CRPV) DNA in rabbit skin following particle-mediated DNA transfer
76. DNA vaccines: Protective immunisations by parenteral, mucosal, and gene-gun inoculations
77. Genetic immunisation is a simple method for eliciting an immune response
78. Theory and in vivo application of electroporative gene delivery
79. In vivo electroporation and stable transformation of skin cells of new-born mice by plasmid DNA
80. In vivo electrically mediated protein and gene transfer in murine melanoma
81. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: An approach to gene therapy of skin aging and other diseases
82. Topical gene transfer into rat skin using elmectroporation
83. Therapeutic gene delivery to the skin